GZMB and acquired epidermolysis bullosa: To explore a causal, mechanistic role in vivo, Hiroyasu et al. [34] utilized a murine model of BP, as well as local and systemic antibody-transfer murine models of epidermolysis bullosa acquisita, to assess the role of GzmB via either GzmB knockout or topical pharmacological inhibition with VTI-1002.